Brooks Laboratories Limited (NSE:BROOKS)

Brooks Laboratories Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Assets

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Equivalents	648.27	66.73	3.08	1.26	0.23	26.05
Cash & Short-Term Investments	654.25	66.73	3.08	1.26	0.23	26.05
Cash Growth	6127.97%	2065.25%	145.58%	440.95%	-99.11%	194.72%
Accounts Receivable	180.65	161.15	199.92	163.16	127.54	176.62
Other Receivables	12.83	25.07	33.48	17.65	3.03	13.69
Receivables	193.48	186.23	233.41	180.84	130.57	190.31
Inventory	110.8	110.22	92.05	96.11	113.03	275.22
Prepaid Expenses	-	2.22	0.83	0.93	0.94	1.77
Other Current Assets	55.31	8.76	9.4	31.36	31.29	118.47
Total Current Assets	1,014	374.15	338.77	310.48	276.06	611.82
Property, Plant & Equipment	183.01	157.09	139.72	136	148.09	1,245
Long-Term Investments	867.22	923.41	735.54	429.13	640.26	2.78
Other Intangible Assets	-	-	0.09	0.73	1.99	6.31
Long-Term Deferred Tax Assets	-	-	-	-	-	13.55
Other Long-Term Assets	112.97	27.08	22.82	28.11	29.57	79.75
Total Assets	2,177	1,482	1,237	904.46	1,096	1,959

Liabilities

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Accounts Payable	110.2	114.37	136.24	154.43	233.7	280
Accrued Expenses	-	25.63	21.96	16.54	23.18	32.34
Short-Term Debt	40.09	59.05	59	50.42	56.64	110.47
Current Portion of Long-Term Debt	-	1.82	0.33	-	-	38.76
Current Portion of Leases	3.56	3.29	2.8	2.43	2.47	1.97
Other Current Liabilities	94.44	13.98	8.11	6.65	14.23	25.25
Total Current Liabilities	248.28	218.14	228.44	230.48	330.21	488.79
Long-Term Debt	14.86	11.91	1.31	-	-	92.91
Long-Term Leases	12.46	9.1	12.4	3.57	6.02	8.49
Pension & Post-Retirement Benefits	-	7.87	6.37	6.8	9.03	12.96
Other Long-Term Liabilities	16.62	8.14	7.39	7.76	11.17	12.78
Total Liabilities	292.22	255.17	255.9	248.6	356.44	615.92

Shareholders' Equity

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Common Stock	294.57	294.57	294.57	262.47	247.03	247.03
Additional Paid-In Capital	-	1,170	1,170	777.24	680	860.21
Retained Earnings	-	-240.68	-486.52	-386.85	-190.93	-236.18
Comprehensive Income & Other	1,590	2.51	2.81	3	3.43	3.84
Total Common Equity	1,885	1,227	981.04	655.85	739.53	874.9
Minority Interest	-	-	-	-	-	468.29
Shareholders' Equity	1,885	1,227	981.04	655.85	739.53	1,343
Total Liabilities & Equity	2,177	1,482	1,237	904.46	1,096	1,959

Additional Metrics

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Total Debt	70.97	85.17	75.83	56.42	65.12	252.59
Net Cash (Debt)	583.28	-18.44	-72.75	-55.16	-64.89	-226.54
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	19.81	-0.63	-2.72	-2.15	-2.63	-9.17
Filing Date Shares Outstanding	29.46	29.46	29.46	26.25	24.7	24.7
Total Common Shares Outstanding	29.46	29.46	29.46	26.25	24.7	24.7
Working Capital	765.56	156.01	110.33	80.01	-54.15	123.04
Book Value Per Share	63.98	41.64	33.30	24.99	29.94	35.42
Tangible Book Value	1,885	1,227	980.95	655.12	737.55	868.59
Tangible Book Value Per Share	63.98	41.64	33.30	24.96	29.86	35.16
Land	-	15.13	15.13	15.13	15.13	187.13
Buildings	-	39.28	38.89	38.89	38.45	447.98
Machinery	-	174.3	166.2	160.19	156.49	771.88
Construction In Progress	-	11.91	-	-	-	151.07

Data Source: S&P Global Market Intelligence Last updated: Nov 7, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 11, 2026

Data Sources Report a data error